Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
03/2003
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055025 For therapy of bacterial infections and neoplasms,
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1017668B1 Method for producing glucoprotamines
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1403441A Prepn of propane diamide compound
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534627 Synthesis and use of amino acid fluorides as peptide coupling reagents
03/18/2003US6534513 Phenylalkanoic acid derivatives
03/18/2003US6534250 Photo-reactive benzocyclobutenones and polymers thereform for self-photocuring, photo-crosslinking and photopatterning without catalysts
03/18/2003CA2141334C Cationic lipids
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2003020266A1 Antineoplastic combinations
03/13/2003WO2002074719A8 Inhibitors of plasmepsins
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003US20030050222 Antineoplastic combinations
03/13/2003US20030049310 Genetic enginnering; inducing antibodies
03/13/2003CA2455126A1 Antineoplastic combinations
03/12/2003EP1291341A1 Compounds exhibiting thrombopoietin-like activities
03/12/2003EP1289936A1 Substituted stilbenes as glucose uptake enhancers
03/12/2003EP1289935A1 Excitatory amino acid receptor modulators
03/12/2003EP1036058B1 Adamantane derivatives
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531495 Potassium channel
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018539A1 Amphoteric lipid compound and use thereof
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
03/06/2003WO2003018537A1 Antiviral protease inhibitors
03/06/2003WO2003018530A1 1,3-glyceride compound having two iodophenyl groups
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045478 Treating diseases such as cardiac and cerebral ischemia or reperfusion injury, sepsis and bacterial meningitis.
03/06/2003CA2458040A1 Antiviral protease inhibitors
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286956A1 Phenyl-substituted 2-enamino-keto nitriles
03/05/2003EP1286954A2 7-substituted fused ring tetracycline compounds
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003CN1400969A Fused imidazolium derivatives
03/04/2003US6528685 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528525 Amidocarboxylic acid derivatives
02/2003
02/27/2003WO2002068592A3 Non-racemic hexafluoreleucine, and methods of making and using it
02/27/2003WO2002038105A3 Novel polyamine analog-amino acid conjugates useful as anticancer agents
02/27/2003US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
02/27/2003US20030040625 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
02/27/2003US20030040483 Compounds with growth hormone releasing properties
02/26/2003EP1285651A1 Melanin concentrating hormone antagonists
02/26/2003EP1284959A1 Compounds for modulating the rage receptor
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003CN1399627A Method of preparing substituted tetracyclines with transition metal-based chemistries
02/25/2003US6525219 4-amino-2-hydroxy-5-substituted-acylanilide compounds and method of using them
02/25/2003US6525215 HIV protease inhibitors
02/25/2003US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders
02/25/2003US6525020 For drug delivery
02/21/2003WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/21/2003CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/20/2003WO2003014061A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions
02/20/2003WO2002088069A3 Compounds useful as intermediates for 4-aminoquinoline derivatives
02/20/2003US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor.
02/20/2003US20030036532 Treatment of infections caused by parasites, especially malaria.
02/20/2003US20030035784 Hair condition
02/19/2003EP1283824A1 Preparation of enantiomerically enriched amine-functionalized compounds
02/19/2003EP1283823A1 Novel mmp-2/mmp-9 inhibitors
02/19/2003EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof
02/19/2003CN1398247A Colchinol derivatives as vascular damaging agents
02/19/2003CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives
02/19/2003CN1101806C Novel gem-difluoro derivatives of phenylacetemide-and phenylacetic acid and their pharmaceutical uses
02/18/2003US6521790 A most preferred compound is (2R)-2-propyl-4-hexynamide, an analog of valproic acid. treating seizures, migraine, psychiatric disorders, neuropathic pain and restlessness syndrome; neuroprotecting a cerebral insult;
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521603 Fungicides for the control of take-all disease of plants
02/13/2003WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
02/13/2003WO2003011028A1 Substituted amides and pest controllers
02/13/2003US20030032671 Propionic acid derivatives
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003US20030030033 Useful as antioxidants in lubricating oils
02/13/2003CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
02/12/2003EP1150942A4 Improved compounds for protein binding
02/12/2003CN1101386C Trisubsted phenyl derivitives
02/11/2003US6518326 Open chain alkoxyamine compounds and their use as polymerization regulators
02/11/2003US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
02/11/2003US6518283 Squaric acid derivatives
02/11/2003CA2092284C Conditioning shampoo composition and method of preparing and using the same
02/06/2003WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
02/06/2003WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
02/06/2003WO2002032871A3 Compounds and methods for treating multidrug resistance
02/06/2003US20030028053 Reacting epoxide (epoxydecane) with ammonia and hydrogen in presence of catalyst
02/06/2003US20030027862 Amino-and amido-diphenyl ethers
02/06/2003US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC
02/06/2003US20030026521 Optical interleaver
02/05/2003EP1281702A2 Calcium receptor active molecules
02/05/2003EP1280765A2 Fluorous tagging compounds and their use
02/05/2003EP1280764A2 Inhibitors of histone deacetylase
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 162